메뉴 건너뛰기




Volumn 52, Issue 23, 2009, Pages 7432-7445

Nonpeptide urotensin-II receptor antagonists: A new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (BENZYL) PIPERAZIN 1 YL] 2 (3,4 DIMETHOXYBENZYL) 2,3 DIHYDRO 1H ISOINDOLE 1,3 DIONE; G PROTEIN COUPLED RECEPTOR; LIGAND; N (2 THIOPHENECARBONYL) {4 (3,4 DIMETHOXYPHENYL) 4 [4 (4 ETHYLPIPERAZIN 1 YL) 1 OXO 2,3 DIHYDRO 1H ISOINDOL 2 YL]BUTYL} AMIDE; N (2 THIOPHENESULFONYL) [4 (3,4 DIMETHOXYPHENYL)] 4 {1,3 DIOXO 4 [4 (1 PHENYLETHYL)PIPERAZIN 1 YL] 2,3 DIHYDRO 1H ISOINDOL 2 YL}BUTYL AMIDE); N (2 THIOPHENESULFONYL) {4 (3,4 DIMETHOXYPHENYL) 4 [4 (4 ETHYLPIPERAZIN 1 YL) 1 OXO 2,3 DIHYDRO 1H ISOINDOL 2 YL] BUTYL}AMIDE; PHTHALIMIDE DERIVATIVE; PIPERAZINO ISOINDOLINONE; PIPERAZINO PHTHALIMIDE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; UROTENSIN RECEPTOR;

EID: 72249117763     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900683d     Document Type: Article
Times cited : (74)

References (73)
  • 1
    • 1942453711 scopus 로고    scopus 로고
    • Urotensin II: The old kid in town
    • For reviews, see: (a)
    • For reviews, see: (a) Onan, D.; Hannan, R. D.; Thomas, W. G. Urotensin II: the old kid in town.TrendsEndocrinol.Metab. 2004, 15, 175-182.
    • (2004) TrendsEndocrinol.Metab. , vol.15 , pp. 175-182
    • Onan, D.1    Hannan, R.D.2    Thomas, W.G.3
  • 2
    • 85047692552 scopus 로고    scopus 로고
    • Urotensin-II and the cardiovascular system - The importance of developing modulators
    • (b) Doggrell, S. A. Urotensin-II and the cardiovascular system - the importance of developing modulators. Expert Opin. Investig. Drugs 2004, 13, 479-487.
    • (2004) Expert Opin. Investig. Drugs , vol.13 , pp. 479-487
    • Doggrell, S.A.1
  • 3
    • 0842266248 scopus 로고    scopus 로고
    • From "gills to pills": Urotensin-II as a regulator of mammalian cardiorenal function
    • (c) Douglas, S. A.; Dhanak, D.; Johns, D. G. From "gills to pills": urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol. Sci. 2004, 25, 76-85.
    • (2004) Trends Pharmacol. Sci. , vol.25 , pp. 76-85
    • Douglas, S.A.1    Dhanak, D.2    Johns, D.G.3
  • 4
    • 20044372934 scopus 로고    scopus 로고
    • Urotensin II: Its function in health and its role in disease
    • (d) Ong, K. L.; Lam, K. S. L.; Cheung, B. M. Y. Urotensin II: its function in health and its role in disease. Cardiovasc. Drugs Ther. 2005, 19, 65-75.
    • (2005) Cardiovasc. Drugs Ther. , vol.19 , pp. 65-75
    • Ong, K.L.1    Lam, K.S.L.2    Cheung, B.M.Y.3
  • 5
  • 6
    • 42049109932 scopus 로고    scopus 로고
    • Biological properties and functional determinants of the urotensin II receptor
    • (f) Proulx, C. D.; Holleran, B. J.; Lavigne, P.; Escher, E.; Guillemette, G.; Leduc, R. Biological properties and functional determinants of the urotensin II receptor. Peptides 2008, 29, 691-699.
    • (2008) Peptides , vol.29 , pp. 691-699
    • Proulx, C.D.1    Holleran, B.J.2    Lavigne, P.3    Escher, E.4    Guillemette, G.5    Leduc, R.6
  • 7
    • 77950552273 scopus 로고    scopus 로고
    • Urotensin-II receptor modulators as potential drugs
    • in press
    • (g) Maryanoff, B. E.; Kinney, W. A. Urotensin-II receptor modulators as potential drugs. J. Med. Chem., in press.
    • J. Med. Chem.
    • Maryanoff, B.E.1    Kinney, W.A.2
  • 9
    • 0032428160 scopus 로고    scopus 로고
    • Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene inmotoneurons of the spinal cord
    • (b) Coulouarn, Y.; Lihrmann, I.; Jegou, S.; Anouar, Y.; Tostivint, H.; Beauvillain, J. C.; Conlon, J. M.; Bern, H. A.; Vaudry, H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene inmotoneurons of the spinal cord. Proc.Natl. Acad. Sci. U.S.A. 1998, 95, 15803-15808.
    • (1998) Proc.Natl. Acad. Sci. U.S.A. , vol.95 , pp. 15803-15808
    • Coulouarn, Y.1    Lihrmann, I.2    Jegou, S.3    Anouar, Y.4    Tostivint, H.5    Beauvillain, J.C.6    Conlon, J.M.7    Bern, H.A.8    Vaudry, H.9
  • 12
    • 42049091846 scopus 로고    scopus 로고
    • Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function
    • (e) Maguire, J. J.; Kuc, R. E.; Kleinz, M. J.; Davenport, A. P. Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function. Peptides 2008, 29, 735-742.
    • (2008) Peptides , vol.29 , pp. 735-742
    • Maguire, J.J.1    Kuc, R.E.2    Kleinz, M.J.3    Davenport, A.P.4
  • 13
    • 0037171726 scopus 로고    scopus 로고
    • Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II
    • (a) Flohr, S.; Kurz, M.; Kostenis, E.; Brkovich, A.; Fournier, A.; Klabunde, T. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 2002, 45, 1799-1805.
    • (2002) J. Med. Chem. , vol.45 , pp. 1799-1805
    • Flohr, S.1    Kurz, M.2    Kostenis, E.3    Brkovich, A.4    Fournier, A.5    Klabunde, T.6
  • 16
    • 0030174350 scopus 로고    scopus 로고
    • Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates
    • Conlon, J. M.; Yano, K.; Waugh, D.; Hazon, N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J. Exp. Zool. 1996, 275, 226-238.
    • (1996) J. Exp. Zool. , vol.275 , pp. 226-238
    • Conlon, J.M.1    Yano, K.2    Waugh, D.3    Hazon, N.4
  • 17
    • 0036157935 scopus 로고    scopus 로고
    • Urotensin II evokes potent vasoconstriction in humans in vivo
    • Bohm, F.; Pernow, J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br. J. Pharmacol. 2002, 135, 25-27.
    • (2002) Br. J. Pharmacol. , vol.135 , pp. 25-27
    • Bohm, F.1    Pernow, J.2
  • 18
    • 0034466374 scopus 로고    scopus 로고
    • Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease
    • Douglas, S. A.; Ohlstein, E. H. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc. Med. 2000, 10, 229-237.
    • (2000) Trends Cardiovasc. Med. , vol.10 , pp. 229-237
    • Douglas, S.A.1    Ohlstein, E.H.2
  • 19
    • 0035030726 scopus 로고    scopus 로고
    • Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats
    • Gardiner, S. M.; March, J. E.; Kemp, P. A.; Davenport, A. P.; Bennett, T. Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br. J. Pharmacol. 2001, 132, 1625-1629.
    • (2001) Br. J. Pharmacol. , vol.132 , pp. 1625-1629
    • Gardiner, S.M.1    March, J.E.2    Kemp, P.A.3    Davenport, A.P.4    Bennett, T.5
  • 20
    • 0035834370 scopus 로고    scopus 로고
    • Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats
    • DOI 10.1016/S0014-5793(01)03015-0, PII S0014579301030150
    • Zou, Y.; Nagai, R.; Yamazaki, T. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 2001, 508, 57-60. (Pubitemid 33055667)
    • (2001) FEBS Letters , vol.508 , Issue.1 , pp. 57-60
    • Zou, Y.1    Nagai, R.2    Yamazaki, T.3
  • 21
    • 0035800017 scopus 로고    scopus 로고
    • Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells
    • Watanabe, T.; Pakala, R.; Katagiri, T.; Benedict, C. R. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 2001, 104, 16-18.
    • (2001) Circulation , vol.104 , pp. 16-18
    • Watanabe, T.1    Pakala, R.2    Katagiri, T.3    Benedict, C.R.4
  • 22
    • 0035208378 scopus 로고    scopus 로고
    • Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues
    • DOI 10.1097/00004872-200112000-00011
    • (a) Matsushita, M.; Shichiri, M.; Imai, T.; Iwashina, M.; Tanaka, H.; Takasu, N.; Hirata, Y. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J. Hypertens. 2001, 19, 2185-2190. (Pubitemid 33135240)
    • (2001) Journal of Hypertension , vol.19 , Issue.12 , pp. 2185-2190
    • Matsushita, M.1    Shichiri, M.2    Imai, T.3    Iwashina, M.4    Tanaka, H.5    Takasu, N.6    Hirata, Y.7
  • 23
    • 34047250447 scopus 로고    scopus 로고
    • Therapeutic potential of blockade of the urotensin II system in systemic hypertension
    • (b) Krum, H.; Kemp,W. Therapeutic potential of blockade of the urotensin II system in systemic hypertension. Curr. Hypertens. Rep. 2007, 9, 53-58.
    • (2007) Curr. Hypertens. Rep. , vol.9 , pp. 53-58
    • Krum, H.1    Kemp, W.2
  • 24
    • 0037042532 scopus 로고    scopus 로고
    • Congestive heart failure and expression of myocardial urotensin II
    • (a) Douglas, S. A.; Tayara, L.; Ohlstein, E. H.; Halawa, N.; Giaid, A. Congestive heart failure and expression of myocardial urotensin II. Lancet 2002, 359, 1990-1997.
    • (2002) Lancet , vol.359 , pp. 1990-1997
    • Douglas, S.A.1    Tayara, L.2    Ohlstein, E.H.3    Halawa, N.4    Giaid, A.5
  • 26
    • 42049105098 scopus 로고    scopus 로고
    • Cardiorenovascular effects of urotensin II and the relevance of the UT receptor
    • (c) Tolle, M.; van der Giet, M. Cardiorenovascular effects of urotensin II and the relevance of the UT receptor. Peptides 2008, 29, 743-763.
    • (2008) Peptides , vol.29 , pp. 743-763
    • Tolle, M.1    Van Der Giet, M.2
  • 29
    • 0037287386 scopus 로고    scopus 로고
    • Increased plasma urotensin II levels in patients with diabetes mellitus
    • (a) Totsune, K.; Takahashi, K.; Arihara, Z.; Sone, M.; Ito, S.; Murakami, O. Increased plasma urotensin II levels in patients with diabetes mellitus. Clin. Sci. 2003, 104, 1-5.
    • (2003) Clin. Sci. , vol.104 , pp. 1-5
    • Totsune, K.1    Takahashi, K.2    Arihara, Z.3    Sone, M.4    Ito, S.5    Murakami, O.6
  • 30
    • 0042071570 scopus 로고    scopus 로고
    • Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects
    • DOI 10.1007/s00125-003-1145-1
    • (b) Wenyi, Z.; Suzuki, S.; Hirai, M.; Hinokio, Y.; Tanizawa, Y.; Matsutani, A.; Satoh, J.; Oka, Y. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects. Diabetologia 2003, 46, 972-976. (Pubitemid 36961321)
    • (2003) Diabetologia , vol.46 , Issue.7 , pp. 972-976
    • Wenyi, Z.1    Suzuki, S.2    Hirai, M.3    Hinokio, Y.4    Tanizawa, Y.5    Matsutani, A.6    Satoh, J.7    Oka, Y.8
  • 31
    • 42149115655 scopus 로고    scopus 로고
    • The role of urotensin II in the metabolic syndrome
    • (c) Ong, K. L.;Wong, L. Y. F.; Cheung, B. M. Y. The role of urotensin II in the metabolic syndrome. Peptides 2008, 29, 859-867.
    • (2008) Peptides , vol.29 , pp. 859-867
    • Ong, K.L.1    Wong, L.Y.F.2    Cheung, B.M.Y.3
  • 33
    • 4043172801 scopus 로고    scopus 로고
    • Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta
    • DOI 10.1016/j.atherosclerosis.2004.03.023, PII S0021915004002308
    • (b) Bousette, N.; Patel, L.; Douglas, S. A.; Ohlstein, E. H.; Giaid, A. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 2004, 176, 117-123. (Pubitemid 39078653)
    • (2004) Atherosclerosis , vol.176 , Issue.1 , pp. 117-123
    • Bousette, N.1    Patel, L.2    Douglas, S.A.3    Ohlstein, E.H.4    Giaid, A.5
  • 36
    • 33645753473 scopus 로고    scopus 로고
    • Non-peptidic urotensin- II receptor modulators
    • For reviews, see: (a)
    • For reviews, see: (a) Jin, J.; Douglas, S. A. Non-peptidic urotensin- II receptor modulators. Expert Opin. Ther. Pat. 2006, 16, 467-479.
    • (2006) Expert Opin. Ther. Pat. , vol.16 , pp. 467-479
    • Jin, J.1    Douglas, S.A.2
  • 38
    • 42049110102 scopus 로고    scopus 로고
    • Nonpeptide urotensin-II receptor agonists and antagonists: Review and structure-activity relationships
    • (c) Lescot, E.; Bureau, R.; Rault, S. Nonpeptide urotensin-II receptor agonists and antagonists: review and structure-activity relationships. Peptides 2008, 29, 680-690.
    • (2008) Peptides , vol.29 , pp. 680-690
    • Lescot, E.1    Bureau, R.2    Rault, S.3
  • 41
    • 33644754588 scopus 로고    scopus 로고
    • The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats
    • (c) Clozel, M.; Hess, P.; Qiu, C.; Ding, S. S.; Rey, M. The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats. J. Pharmacol. Exp. Ther. 2006, 316, 1115-1121.
    • (2006) J. Pharmacol. Exp. Ther. , vol.316 , pp. 1115-1121
    • Clozel, M.1    Hess, P.2    Qiu, C.3    Ding, S.S.4    Rey, M.5
  • 48
    • 27844466269 scopus 로고
    • N-Methoxy-N-methylamides as effective acylating agents
    • Nahm, S.; Weinreb, S. M. N-Methoxy-N-methylamides as effective acylating agents. Tetrahedron Lett. 1981, 22, 3815-3818.
    • (1981) Tetrahedron Lett. , vol.22 , pp. 3815-3818
    • Nahm, S.1    Weinreb, S.M.2
  • 49
    • 0036065054 scopus 로고    scopus 로고
    • A simple protocol for the one pot synthesis of chiral secondary benzylic alcohols by catalytic enantioselective reduction of aromatic ketones
    • Ponzo, V. L.; Kaufman, T. S. A simple protocol for the one pot synthesis of chiral secondary benzylic alcohols by catalytic enantioselective reduction of aromatic ketones. Synlett 2002, 7, 1128-1130.
    • (2002) Synlett , vol.7 , pp. 1128-1130
    • Ponzo, V.L.1    Kaufman, T.S.2
  • 50
    • 33751183730 scopus 로고
    • Mild and selective palladium(0)-catalyzed deallylation of allylic amines. Allylamine and diallylamine as very convenient ammonia equivalents for the synthesis of primary amines
    • Garro-Helion, F.; Merzouk, A.; Guibe, F. Mild and selective palladium(0)-catalyzed deallylation of allylic amines. Allylamine and diallylamine as very convenient ammonia equivalents for the synthesis of primary amines. J. Org. Chem. 1993, 58, 6109-6113.
    • (1993) J. Org. Chem. , vol.58 , pp. 6109-6113
    • Garro-Helion, F.1    Merzouk, A.2    Guibe, F.3
  • 51
    • 0345276532 scopus 로고    scopus 로고
    • Highly enantioselective hydrogen- Transfer reductive amination: Catalytic asymmetric synthesis of primary amines
    • (a) Kadyrov, R; Riermeier, T. H. Highly enantioselective hydrogen- transfer reductive amination: catalytic asymmetric synthesis of primary amines. Angew. Chem., Int. Ed. 2003, 42, 5472-5474.
    • (2003) Angew. Chem., Int. Ed. , vol.42 , pp. 5472-5474
    • Kadyrov, R.1    Riermeier, T.H.2
  • 52
    • 72249118825 scopus 로고    scopus 로고
    • Each enantiomer of intermediate XV was analyzed by chiral HPLC (seeExperimental Section)
    • (b) Each enantiomer of intermediate XV was analyzed by chiral HPLC (seeExperimental Section).
  • 53
    • 0037031625 scopus 로고    scopus 로고
    • Aqueous hydroxide as a base for palladium-catalyzed amination of aryl chlorides and bromides
    • Kuwano, R.; Utsunomiya, M.; Hartwig, J. F. Aqueous hydroxide as a base for palladium-catalyzed amination of aryl chlorides and bromides. J. Org. Chem. 2002, 67, 6479-6486.
    • (2002) J. Org. Chem. , vol.67 , pp. 6479-6486
    • Kuwano, R.1    Utsunomiya, M.2    Hartwig, J.F.3
  • 54
    • 72249098091 scopus 로고    scopus 로고
    • 50 value of 460 nM
    • 50 value of 460 nM.
  • 55
    • 14744274245 scopus 로고    scopus 로고
    • Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: Comparison with angiotensin II receptors
    • DOI 10.1016/j.peptides.2004.11.018
    • Qi, J.-S.; Minor, L. K.; Smith, C.; Hu, B.; Yang, J.; Andrade- Gordon, P.; Damiano, B. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides 2005, 26, 683-690. (Pubitemid 40326887)
    • (2005) Peptides , vol.26 , Issue.4 , pp. 683-690
    • Qi, J.-S.1    Minor, L.K.2    Smith, C.3    Hu, B.4    Yang, J.5    Andrade-Gordon, P.6    Damiano, B.7
  • 56
    • 72249085771 scopus 로고    scopus 로고
    • 50=150 nM)
    • 50=150 nM).
  • 58
    • 0038606902 scopus 로고    scopus 로고
    • The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors
    • Herold, C. L.; Behm, D. J.; Buckley, P. T.; Foley, J. J.; Wixted, W. E.; Sarau, H. M.; Douglas, S. A. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors. Br. J. Pharmacol. 2003, 139, 203-207.
    • (2003) Br. J. Pharmacol. , vol.139 , pp. 203-207
    • Herold, C.L.1    Behm, D.J.2    Buckley, P.T.3    Foley, J.J.4    Wixted, W.E.5    Sarau, H.M.6    Douglas, S.A.7
  • 60
    • 72249106860 scopus 로고    scopus 로고
    • Cerep Seattle, WA; an independent contract laboratory, performed standardized binding assays on receptors and ion channels. Each results was expressed as percent inhibition of a control specific binding (mean values, n=2; h, human)
    • Cerep (Seattle, WA; www.cerep.com), an independent contract laboratory, performed standardized binding assays on receptors and ion channels. Each results was expressed as percent inhibition of a control specific binding (mean values, n=2; h, human).
  • 61
    • 72249120159 scopus 로고    scopus 로고
    • note
    • + channel; Cl- channel; norepinephrine transporter; dopamine transporter.
  • 62
    • 72249110867 scopus 로고    scopus 로고
    • Schrodinger, Inc.: 1500 SW First Avenue, Suite 1180, Portland, OR
    • Maestro 8.5.207; Schrodinger, Inc.: 1500 SW First Avenue, Suite 1180, Portland, OR.
    • Maestro 8.5.207
  • 63
    • 33645941402 scopus 로고
    • The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin
    • Jorgensen,W. L.; Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 1988, 110, 1657-1666.
    • (1988) J. Am. Chem. Soc. , vol.110 , pp. 1657-1666
    • Jorgensen, W.L.1    Tirado-Rives, J.2
  • 64
    • 4043171970 scopus 로고    scopus 로고
    • The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii
    • Qui, D.; Shenkin, P. S.; Hollinger, F. P.; Still, C. W. The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii. J. Phys. Chem. A 1997, 101, 3005-3014.
    • (1997) J. Phys. Chem. A , vol.101 , pp. 3005-3014
    • Qui, D.1    Shenkin, P.S.2    Hollinger, F.P.3    Still, C.W.4
  • 65
    • 0142236572 scopus 로고    scopus 로고
    • Low mode search. An efficient, automated computational method for conformational analysis: Application to cyclic and acyclic alkanes and cyclic peptides
    • (a) Kolossvary, I.; Guida, W. C. Low mode search. An efficient, automated computational method for conformational analysis: application to cyclic and acyclic alkanes and cyclic peptides. J. Am. Chem. Soc. 1996, 118, 5011-5019.
    • (1996) J. Am. Chem. Soc. , vol.118 , pp. 5011-5019
    • Kolossvary, I.1    Guida, W.C.2
  • 66
    • 0000147236 scopus 로고    scopus 로고
    • 80 and flexible docking of 9-deazaguanine inhibitors into PNP
    • 80 and flexible docking of 9-deazaguanine inhibitors into PNP. J. Comput. Chem. 1999, 20, 1671-1684.
    • (1999) J. Comput. Chem. , vol.20 , pp. 1671-1684
    • Kolossvary, I.1    Guida, W.C.2
  • 67
    • 72249092059 scopus 로고    scopus 로고
    • Version 3.0; Schrodinger, LLC: New York
    • Phase, Version 3.0; Schrodinger, LLC: New York, 2008.
    • (2008) Phase
  • 68
    • 67650245849 scopus 로고    scopus 로고
    • Generation of novel, potent urotensin-II receptor antagonists by alkylation-cyclization of isoindolinone C3-carbanions
    • Luci, D. K.; Lawson, E. C.; Ghosh, S.; Kinney, W. A.; Smith, C. E.; Qi, J.; Wang, Y.; Minor, L. K.; Maryanoff, B. E. Generation of novel, potent urotensin-II receptor antagonists by alkylation-cyclization of isoindolinone C3-carbanions. Tetrahedron Lett. 2009, 50, 4958-4961.
    • (2009) Tetrahedron Lett. , vol.50 , pp. 4958-4961
    • Luci, D.K.1    Lawson, E.C.2    Ghosh, S.3    Kinney, W.A.4    Smith, C.E.5    Qi, J.6    Wang, Y.7    Minor, L.K.8    Maryanoff, B.E.9
  • 69
    • 34247244635 scopus 로고    scopus 로고
    • Definition of new pharmacophores for nonpeptide antagonists of urotensin-II. Comparison with the 3D-structure of human urotensin- II and URP
    • (a) Lescot, E.; Sopkova-de Oliveira Santos, J.; Dubessy, C.; Oulyadi, H.; Lesnard, A.; Vaudry, H.; Bureau, R.; Rault, S. Definition of new pharmacophores for nonpeptide antagonists of urotensin-II. Comparison with the 3D-structure of human urotensin- II and URP. J. Chem. Inf. Model. 2007, 47, 602-612.
    • (2007) J. Chem. Inf. Model. , vol.47 , pp. 602-612
    • Lescot, E.1    Sopkova-de Oliveira Santos, J.2    Dubessy, C.3    Oulyadi, H.4    Lesnard, A.5    Vaudry, H.6    Bureau, R.7    Rault, S.8
  • 70
    • 50849111783 scopus 로고    scopus 로고
    • Three-dimensional model of the human urotensin-II receptor: Docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model
    • (b) Lescot, E.; Sopkova-de Oliveira Santos, J.; Colloc'h, N.; Rodrigo, J.; Milazzo- Segalas, I.; Bureau, R.; Rault, S. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model. Proteins 2008, 73, 173-184.
    • (2008) Proteins , vol.73 , pp. 173-184
    • Lescot, E.1    Sopkova-de Oliveira Santos, J.2    Colloc'h, N.3    Rodrigo, J.4    Milazzo-Segalas, I.5    Bureau, R.6    Rault, S.7
  • 71
    • 0001797411 scopus 로고
    • Asymmetric hydrogenation of 3-oxo carboxylates using BINAP-ruthenium complexes: (R)-(-)-methyl 3-hydroxybutanoate
    • Kitamura, M.; Tokunaga, M.; Ohkuma, T.; Noyori, R. Asymmetric hydrogenation of 3-oxo carboxylates using BINAP-ruthenium complexes: (R)-(-)-methyl 3-hydroxybutanoate. Org. Synth. 1993, 71, 1-13.
    • (1993) Org. Synth. , vol.71 , pp. 1-13
    • Kitamura, M.1    Tokunaga, M.2    Ohkuma, T.3    Noyori, R.4
  • 73
    • 0029102720 scopus 로고
    • Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors
    • (b) Marchese, A.; Heiber, M.; Nguyen, T.; Heng, H. H.; Saldivia, V. R.; Cheng, R.; Murphy, P. M.; Tsui, L. C.; Shi, X.; Gregor, P. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 1995, 29, 335-344.
    • (1995) Genomics , vol.29 , pp. 335-344
    • Marchese, A.1    Heiber, M.2    Nguyen, T.3    Heng, H.H.4    Saldivia, V.R.5    Cheng, R.6    Murphy, P.M.7    Tsui, L.C.8    Shi, X.9    Gregor, P.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.